5329672025-07-012025-09-305329672025-09-305329672025-03-315329672025-04-012025-09-305329672025-07-012025-09-30in-capmkt:OtherExpenses1Member5329672025-04-012025-09-30in-capmkt:OtherExpenses1Member5329672025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15329672025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15329672025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15329672025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532967KIRIINDUS0INE415I01015KIRI INDUSTRIES LIMITEDMain BoardEquity2025-04-012026-03-312025-11-072025-11-03INRLakhsQuarterlySecond quarterSingle segmentThe Company operates in a single segment i. e. Dyes, Dyes Intermediates and basic chemicals. As per Ind As 108 - Operating Segments, the Operation of the Company fall under Chemical Business which is considered to constitute as single primary segment.2025-11-0711:00:002025-11-0713:55:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated2134368000637000021407380001418856000161687000252480001281530006052160001165220005372710002992953000-8522150000-852215000772000-58319000-575470000-794668000000991137000196469000-471899000-2754300001964690000-471899000-27543000060022600010-4.74-4.5400-4.74-4.541. The Company operates in a single segment i. e. Dyes, Dyes Intermediates and Basic Chemicals. As per Ind As 108 - Operating Segments, the Operation of the Company fall under Chemical Business which is considered to constitute as single primary segment. <BR> 2. The above results have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereafter. <BR> 3. The above financial results were reviewed by the Audit Committee and thereafter approved by the Board of Directors at their meeting held on November 07, 2025. <BR> 4. Previous period figures have been regrouped and rearranged wherever considered necessary. <BR> 5. In Standalone Financials for H1FY26, the other income includes Equity Dividend Income of Rs. 3,000.00 Lakhs from Lonsen Kiri Chemical Industries Ltd. declared for the year ended March 31, 2025. <BR> 6. During Q2FY26, the company has allotted 43,93,592 Equity Shares on preferential basis to the Promoter and members of the Promoter Group upon conversion of Warrants and accordingly, the Issued, Subscribed and Paid-up Equity Share Capital of the company stands increased to INR 60,02,25,540/- divided into 6,00,22,554 fully paid-up equity shares of INR 10/- each. <BR> 7. During the previous fiancial year, the company adopted equity method of consolidation of financial statements as per Ind AS 28, 110 & 111 as against proportionate consolidation method earlier used for recognition of group interest in joint venture having management control. Accordingly, the effect of such change in presentation of consolidated financial statements (Profit and Loss statements) of earlier periods have been disclosed by the company as disclosed in PDF. <BR> 8. Relevant material information of a major investment in DyStar Group (Company holds 37.57% share holding) for the quarter ended September 30, 2025. <BR> Particulars US$ in Mn. INR in Mn. * <BR> Revenue 175.2 15,556.41 <BR> Gross Margin 53.8 4,777.03 <BR> EBIT 23.8 2,113.26 <BR> EAT 24.8 2,202.05 <BR> ( * 1 US$ = 88.7923 INR) <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated41555740003540220004509596000280187200037049300013811000247566000120066500023242200010207250005887554000-13779580000-13779580001083000-70294000-692110000-13087470000001606570000297823000-467128000-1693050002978230000-467128000-16930500060022600010-2.98-2.8500-2.98-2.85Other Expenses537271000Other Expenses10207250008862394000632206000074000119100000293787520001000000315634900016373100033201800002888530003086268000455699180001614950000551688000104599700017767900002329300024620100037506200040190310003175700022178400058875220000051457440000600226000321920390003279226500020000327922850001218508800000023449360001453002400079581000000146096050004068800011678700025190500002635837000129706700039735920007250200061330003323000405555000018665155000514574400000-80340000397610000-69063000-17604890006134000-13630800005088460000-2345100011845570002324220000-34230006468000012095350003994670000007021300000785000-46422400001120890000-257068000-354022000-120066500001066700005789080000028252240000000001052877000000000000000012443010000003540220000008820680000007952400000000724700000791740001290000012003820000-487510001903430001651319000016513190001254710001776790000Remeasurements of the defined benefits plans-1485000-1485000Remeasurements of the defined benefits plans-2905000-290500000Exchange differences in translating financial statements of foreign subsidiary-470414000-470414000Exchange differences in translating financial statements of foreign subsidiary-464223000-46422300000-471899000-467128000